Surrogacy News

  • ALL
  • Surrogacy techniques
  • Company News
  • Surrogacy Industry News

    • Surrogacy Services in Kyrgyzstan: Legal, Safe and Professional Fertility Solutions

    2025-03-26

    Surrogacy is a form of assisted reproduction that uses modern medical technology to help families unable to have children naturally realize their desire to have children. According to the source of embryos, surrogacy is divided into two categories: Complete surrogacy (gestational surrogacy): the surrogate mother only provides the uterus, and the embryo is formed by in vitro fertilization of the spermatozoa from the commissioner or donor, with no genetic link to the baby. Partial surrogacy (genetic surrogacy, which has been phased out): the surrogate mother also provides the egg, which is fertilized with the sperm of the client.In Kyrgyzstan, surrogacy is predominantly full surrogacy, which strictly follows the norms of the Family Code and the Law on Protection of Citizens’ Health, ensuring legal and ethical compliance. The global infertility rate is increasing year by year, surrogacy becomes the core solution for the following groups:Infertile couples: unable to conceive naturally due to physical diseases, uterine defects or repeated miscarriages.Senior women: with declining ovarian function or high risk of pregnancy, needing a healthy uterus to complete their fertility.Singles and LGBTQ+: Kyrgyz law allows singles and same-sex couples to form families through surrogacy.Families at risk of genetic diseases: avoiding genetic diseases through embryo genetic screening (PGD/ PGS).Surrogacy is not only a breakthrough in medical technology, but also a respect for equal reproductive rights and family integrity. Benefits for the commissioning party: Legal security: the birth certificate directly labels the commissioning party as the legal parent without additional litigation.Cost-effective: the cost is about $50,000-$70,000, only one-third of the cost in the United States.Mature technology: using three generations of IVF technology (IVF+ICSI), the success rate is as high as 65%-70%. Benefits for surrogate mothers: Economic compensation: average income of $20,000-$40,000, improving the quality of family life.Medical protection: free maternity checkups, delivery and postnatal care throughout…

    Anesthesia Options for Egg Collection: The Perfect Balance of Safety, Painlessness and Fertility Protection

    2025-03-20

    How to make the egg retrieval procedure, the core part of IVF, “painless”?In IVF treatment, egg retrieval is a key step in obtaining high-quality eggs. According to the data of Global Fertility Center, 87% of patients who undergo egg retrieval while awake feel moderate pain or more (VAS score ≥4). How do you choose an anesthesia regimen that guarantees a smooth procedure and ensures egg quality? In this article, we will analyze the scientific basis and clinical data of the two mainstream analgesic options. Comparison of analgesic options for egg retrieval: Dulcolax vs general anesthesiaIn-depth analysis of Dulcolax analgesia As a traditional analgesic, Dulcolax (pethidine) works by blocking the μ-type opioid receptors: Drug metabolism properties:Onset of action 15 minutes after intramuscular injection, blood concentration maintained for 2-4 hours.Half-life 3-4 hours, hepatic metabolism to toxic products (nortriptyline).Clinical Effectiveness Data:Pain relief only 58% (Human Reproduction 2023)Nausea and vomiting occurred in 25% of patients and respiratory depression (respiratory rate <12 breaths/min) occurred in 15%Applicable Population:Normal ovarian position (<3cm from vaginal vault)Expected number of eggs to be retrieved <8Patients with high pain toleranceTechnological innovations in general anesthesia Modern intravenous anesthesia uses the golden combination of propofol + remifentanil: Onset and recovery time:Consciousness disappears within 30 seconds, fully awake in 5-10 minutes after the operation.Half-life of the drug is only 40 minutes, no accumulation effect.Precise anesthesia management:Target-controlled infusion (TCI) technology to maintain BIS value of 40-60Full monitoring of oxygen saturation (SpO₂＞95%), ETCO₂ (35-45mmHg)Clinical Advantage Data:98% effective rate of pain controlEgg retrieval time reduced by 30% (average 8 minutes to complete the procedure) Dispelling Anesthesia Myths: Scientific Data Speaks for ItselfAnesthesia affects intelligence? A 100,000-person cohort study published in JAMA 2023 confirms: Single general anesthesia has no effect on cognitive function (difference in MMSE scores <0.5 points)Complete drug metabolism takes only 6-8 hoursMemory tests return to…

    Why does the lining of the uterus thin? Three major culprits and scientific solutions

    2025-03-20

    How is the lining of the uterus, the “soil” that nurtures life, being damaged?The lining of the uterus is the “golden soil” where embryos are laid, and should ideally be 7-12mm thick at the time of ovulation, but about 25% of infertile women around the world suffer from a thin endometrial lining (<7mm). This seemingly simple layer of mucosal tissue is actually a sophisticated collaborative system of hormone regulation, cell regeneration and angiogenesis. Scientific Diagnostic Criteria for Thin EndometriumThe thickness of the endometrial lining is monitored dynamically by vaginal ultrasound and is determined in conjunction with the menstrual cycle: Early hyperplasia (day 5-7 of menstruation): 3-5mmOvulatory phase (14th day of menstruation): ≥7mm (optimal thickness for implantation)Luteal phase (21st day of menstruation): 10-14mmPathological endometrial thinness is diagnosed if the thickness at ovulation is <7mm for two consecutive cycles. 2023 Fertility and Sterility study states that the clinical pregnancy rate in such patients is only 18%, significantly lower than the 42% in the normal population.Three major culprits cause endometrial thinning Estrogen deficiency: when serum estradiol is <200pg/ml, the growth of endometrial glands is restricted.Luteal insufficiency: Progesterone <10ng/ml leads to impaired mesenchymal metaplasiaTypical case: thin endothelium in 67%** of patients with polycystic ovary syndrome (PCOS)Data support: 10% elevation of the stress hormone cortisol decreases endometrial thickness by 0.3mm (Human Reproduction 2022) Endometrial polyps: even <1cm polyps can reduce local blood flow by up to 40 Chronic endometritis: decreased endometrial repair with CD138 positive cells >5/HPFTuberculous endometritis: leads to permanent damage to the basement membrane, with a recurrence rate of up to 35 Post-scraping: 1 abortion leads to a 0.8mm decrease in endothelial thickness, and the probability of damaging the basal layer for more than 3 abortions reaches 72Uterine adhesion: the pregnancy rate of patients with moderate adhesion is only 15%, and the rate…

    A Scientific Guide to Preparing for Pregnancy: Laying the Foundation for a Healthy Life

    2025-03-19

    In today’s highly advanced medical world, “unplanned pregnancies” are still a common phenomenon in many families. More and more couples are beginning to realize that just as a house needs a good foundation before it can be built, so too does a systematic preparation for conceiving a new life. In this article, we will analyze the international cutting-edge pregnancy preparation science system to help parents-to-be build the best conditions for pregnancy from physiological, psychological, environmental and other dimensions. 　　I. Strategic significance of fertility planning　　Biological basis of the golden childbearing period　　The optimal reproductive age for women is 25-30 years old (peak ovarian reserve function), and it is recommended that men complete childbearing before the age of 40 (sperm DNA fragmentation index ≤15% is preferred). 35 years of age and above, the risk of Down’s syndrome increases from 1/1000 to 1/400; the risk of autism for offspring of men over 40 years of age increases by 50% (data from the New England Journal of Medicine).　　Interdisciplinary Fertility Assessment　　Recommended 6-12 months in advance:　　Female: AMH test (normal value 2-6.8 ng/ml) + sinus follicle count (AFC ≥5)　　Men: semen analysis (WHO criteria: concentration ≥15 million/ml, viability ≥32%)　　Genetic screening: extended carrier screening (ECS) covering 500+ genes for cystic fibrosis, spinal muscular atrophy, etc.　　Second, the scientific program of nutritional management　　Precise regulation of body composition　　Body fat percentage (ideal value for women 21-33%) is measured by DEXA scanning, together with personalized diet:　　Trace elements: Zinc (15mg/d) to enhance sperm quality, Vitamin D (2000IU/d) to improve follicle development　　Antioxidant system: Coenzyme Q10 (600mg/d) to reduce egg mitochondrial damage, Lycopene (30mg/d) to reduce sperm oxidative stress　　Folate metabolism gene test　　MTHFR gene polymorphism testing guides precise supplementation:　　CC type: 0.4mg/d　　CT type: 0.8mg/d　　TT type: 5mg/d (doctor supervision required) III. Environmental Toxin Defense System　　Chemical Exposure Hot Spot Screening　　Focus on:　　Bisphenol A (BPA): avoid heating plastic containers, choose BPA-free products　　Perfluorinated compounds (PFAS):…

    Evidence-Based Practice Guidelines for Management of Estimated Dates of Delivery and Expired Pregnancy in Surrogate Mothers

    2025-03-19

    Expected date of delivery (EDD) is a core time node in perinatal medicine, and its precise management directly affects maternal and infant outcomes. This article analyzes the scientific response from four dimensions: EDD calculation error mechanism, risk stratification of expired pregnancy, clinical monitoring strategy and intervention timing. 　　First, surrogate mother due date calculation principle and error analysis　　Standard calculation rules　　Naegele formula: based on the first day of the last menstrual period (LMP) + 280 days (28-day menstrual cycle), error ± 5 days;　　Ultrasound correction: head and rump length (CRL) is most accurately determined in early pregnancy (7-13⁶ weeks), with an error of ≤3 days per gestational week (ACOG guidelines).　　Sources and incidence of error　　Only 4% of surrogate mothers deliver on the day of EDD, and the normal delivery interval is 37⁰-41⁶ weeks of gestation (90% of cases);　　For menstrual cycles >35 days, the EDD needs to be corrected for the day of ovulation + 266 days (40% decrease in the rate of expired pregnancies after correction).　　II. Pathologic risks of expired pregnancy (≥42⁰ weeks)　　Decline in placental function　　30% reduction in placental villous surface area and decreased oxygen diffusion capacity (umbilical artery S/D ratio >3.0 suggests hypoxia);　　Increased incidence of oligohydramnios (AFI < 5 cm) to 30% (normal pregnancy only 8%). 　　Fetal complications 　　3-fold increased risk of meconium aspiration syndrome (MAS) (2% in term vs 0.7% in full term); 　　12% incidence of macrosomia (>4000 g) (8% in full-term pregnancy) and 50% increased risk of shoulder dystocia.　　III. Clinical management pathway for surrogate mothers after 41 weeks of pregnancy　　Fetal monitoring intensive program　　Fetal movement count: <10 movements/2 hours or 50% reduction from baseline requires urgent evaluation (92% predictive value of NST abnormality); 　　Biophysical scoring (BPP): 2 times per week (score ≤6 suggests termination of pregnancy); 　　Ultrasound Doppler: umbilical artery PI >95th percentile combined with middle cerebral artery PI <5th percentile suggests…

    Systematic analysis of ICSI fertilization failure and coping strategy

    2025-03-18

    I. Pathological mechanisms of ICSI fertilization failure　　Although ICSI (intracytoplasmic single sperm microinjection) technology can overcome severe male factor infertility (e.g., sperm concentration <1×10⁶/mL or motility <5%), Total Fertilization Failure (TFF) still occurs in 3%-5% of cycles. The core mechanism lies in defective egg activation and involves the following key components: 　　Abnormal calcium oscillatory signaling: during normal fertilization, sperm-specific phospholipase C (PLCζ) triggers cyclic fluctuations in intracytoplasmic calcium ion concentration (0.1-1 μM for 2-4 hours) in the oocyte, which activates calmodulin-dependent kinase (CaMKII) and initiates embryonic development. If there is a mutation in the sperm PLCζ gene (e.g. c.1450G>T) or dysfunction of the oocyte calcium release channel (IP3 receptor), this will result in disruption of calcium signaling.　　Insufficient oocyte maturity: the cortical granules of GV-stage oocytes have not fully migrated to the subcellular membrane, which makes them susceptible to multiple fertilization; whereas the meiotic arrest of MI-stage oocytes, with reduced PLCζ sensitivity, results in a fertilization failure rate of 40%.　　Second, the technological breakthrough of assisted oocyte activation (AOA)　　To address the activation defects, the clinical use of Artificial Oocyte Activation (AOA) technology, which restores calcium oscillations through exogenous calcium ion carriers or chemical stimulation:　　Calcium ion carriers (Ionomycin):　　Mechanism of action: binds to oocyte membrane calcium channels and induces transient calcium inward flow (at concentrations up to 5 μM), mimicking physiologic calcium oscillations.　　Clinical data: 2017 Meta-analysis showed that AOA with Ionomycin resulted in an increase in fertilization rate from 12% to 72%, an increase in the rate of good quality embryos from 18% to 45%, and a 3-fold increase in live birth rate.　　Strontium Chloride (SrCl₂):　　Mechanism of action: triggers persistent calcium oscillations through TRPV3 channels, especially for patients with PLCζ defects.　　Scenario of application: in cases unresponsive to Ionomycin, SrCl₂ (10 mM treatment for 15 min) results in a fertilization rate of 65%. III. Precision pathway for…

    Clinical significance and systematic management guidelines for NT examination

    2025-03-18

    I. Medical definition and technical principle of NT examination　　NT (nuchal translucency) refers to the transparent area formed by the accumulation of subcutaneous lymphatic fluid in the posterior part of the fetal neck, the maximum thickness of which is measured by high-frequency ultrasound (5-7 MHz probe) in the median sagittal section of the fetus. This structure is prominent at 11-14 weeks of gestation, as the fetal lymphatic system is not fully developed at this stage and some of the lymphatic fluid is temporarily retained. Chromosomal abnormalities (e.g., trisomy 21) can lead to structural abnormalities in the lymphatic vessels, which can obstruct the return of lymphatic fluid and increase the thickness of the NT. Studies show that 65% of fetuses with NT ≥3.5 mm have chromosomal abnormalities or severe congenital heart disease, and every 1 mm increase in NT raises the risk of trisomy 21 by 32 times.　　Timing and operation standardization　　According to the guidelines of the International Federation of Gynecology and Obstetrics (FIGO), NT examination should be strictly controlled from 11 weeks + 0 days to 13 weeks + 6 days (head and hip diameter 45-84 mm). Earlier than this, the NT is not sufficiently formed, and later than this, abnormal lymphatic fluid may be absorbed, leading to a missed diagnosis. There are three technical requirements to be met during the procedure:　　The fetus must be placed in a natural supine position with the spine at a 45° angle to the probe;　　The ultrasound image should clearly show the nasal bone, the fourth ventricle and the cleft palate;　　The measurement point should be chosen at the widest part of the hyaloid layer, and the maximum value should be repeated three times with an error of <0.1 mm. 　　Clinical grading and management pathway of the test results 　　Low risk (NT <2.5 mm): probability of chromosomal abnormality…

    Complete Clinical Path and Technical Analysis of Artificial Insemination

    2025-03-18

    Artificial Insemination (AI) is an assisted reproductive technology in which processed semen is injected directly into the female reproductive tract (mainly intrauterine insemination) through non-coital means. The core principle is to increase the probability of sperm meeting the egg by optimizing the path and timing of sperm delivery. Depending on the source of sperm, it is categorized into artificial insemination by husband (AIH), which is suitable for men with mild to moderate oligozoospermia or sexual dysfunction, and artificial insemination by donor (AID), which is for couples with azoospermia or a high risk of genetic disorders. Compared to In Vitro Fertilization (IVF), the advantages of AI are that it is easy to perform (on average, it takes 15 minutes), inexpensive (the cost of a single cycle is about 1/10 of that of IVF), and closer to the physiological process of natural pregnancy.　　Stage 1: Rigorous medical evaluation (1-30 days)　　Prior to initiating treatment, the patient completes a systematic medical evaluation to rule out contraindications and optimize the conditions for pregnancy:　　Female Fertility Assessment　　Ovarian reserve function: Ovarian responsiveness is assessed by anti-Müllerian hormone (AMH) testing (threshold ≥ 1.1 ng/mL) and sinus follicle count (AFC ≥ 5).　　Tubal patency: hysterosalpingography (HSG) was preferred, with referral for laparoscopy or direct IVF if bilateral obstruction was demonstrated.　　Uterine environment: transvaginal ultrasound to measure endometrial thickness (≥7 mm at ovulation is ideal), and hysteroscopy to rule out polyps or adhesions if necessary.　　Male semen analysis　　Criteria for semen optimization: After processing by density gradient centrifugation, the total number of forward-moving spermatozoa needs to be ≥5×10⁶ and the DNA fragmentation index (DFI) <30%. For patients with severe oligospermia (e.g., total motile sperm <1×10⁶), it is recommended to upgrade to ICSI technology. 　　Frozen semen processing: the donor specimen should be quick-frozen in liquid nitrogen (cooling rate -20°C/min) and resuscitated in a 37°C water bath, and…

    Advances in the Clinical Use of Luteal Phase Ovulation Regimens

    2025-03-18

    　　Since 1998, when Rombauts first reported the success of luteal phase ovulation in obtaining mature oocytes, this protocol has become an important tool in reproductive medicine. Initially, it was used for emergency fertility preservation in patients with malignant tumors, and its rapid oocyte acquisition properties bought valuable time for cancer treatment. In recent years, as the proportion of patients with low ovarian reserve (DOR) and low ovarian response (POR) has risen and the efficacy of traditional ovulation regimens has been limited, luteal phase ovulation has become increasingly advantageous and continues to be used to optimize clinical outcomes through technological innovations.　　I. Theoretical basis of luteal phase ovulation induction　　According to traditional theory, there is only one follicular recruitment wave in a single menstrual cycle. However, Baerwald et al. revealed that there can be 2-3 follicular waves in a woman’s menstrual cycle, including the follicular ovulation wave and the luteal phase non-ovulation wave. The dominant follicle in the luteal phase is atretic due to inhibition of gonadotropin (Gn) secretion by the hyperestrogenic environment. Application of exogenous follicle stimulating hormone (FSH) reverses this atresia process, while high estrogen levels or exogenous trigger drugs in the luteal phase still induce luteinizing hormone (LH) peaks, which is the core mechanism of ovulation promotion in the luteal phase. The maturity of embryo freezing and thawing technology further guarantees the developmental potential of embryos obtained from this program.　　Advantages of Clinical Application for Specific Population Groups　　Patients with low ovarian response (POR) and low reserve (DOR)　　Comparison of traditional regimens: Li et al. found that the luteal phase ovulation group had a significantly higher number of eggs (3.2±1.5 vs. 2.1±1.2), a higher rate of high-quality embryos (45% vs. 32%) than the microstimulation regimen, and a 40% reduction in cycle cancellation rate.　　Breakthrough in dual-stimulation regimen: consecutive follicular phase + luteal phase ovulation…

    navigation menu

    tatecare

    Kyrgyzstan Surrogacy Agency,Global IVF Hospitals,International Surrogate Mother Recruitment